BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Valsartan

A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION.

297+ PubMed studies analyzed · 46 RCTs · Evidence Score: 56.1

Research Domains

Valsartan has been studied across 18 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 😴 Sleep, 🔬 Inflammation. The primary research focus is ❤️ Cardiovascular with 70% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Valsartan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Irbesartan
5 shared targets
Oseltamivir
3 shared targets
Losartan
6 shared targets
Lamivudine
3 shared targets
Lidocaine
3 shared targets
Gabapentin
2 shared targets
Olmesartan
3 shared targets
Tobramycin
2 shared targets
Tigecycline
2 shared targets
Metronidazole
2 shared targets
Loading evidence profile...

This evidence profile for Valsartan is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.